Tsveta Milanova - Net Worth and Insider Trading
Tsveta Milanova Net Worth
The estimated net worth of Tsveta Milanova is at least $780,409 dollars as of 2024-11-13. Tsveta Milanova is the Chief Commercial Officer of Agios Pharmaceuticals Inc and owns about 13,234 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $780,409. Details can be seen in Tsveta Milanova's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tsveta Milanova has not made any transactions after 2024-01-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tsveta Milanova
Tsveta Milanova Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tsveta Milanova owns 1 companies in total, including Agios Pharmaceuticals Inc (AGIO) .
Click here to see the complete history of Tsveta Milanova’s form 4 insider trades.
Insider Ownership Summary of Tsveta Milanova
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2024-01-24 | Chief Commercial Officer |
Tsveta Milanova Latest Holdings Summary
Tsveta Milanova currently owns a total of 1 stock. Tsveta Milanova owns 13,234 shares of Agios Pharmaceuticals Inc (AGIO) as of January 24, 2024, with a value of $780,409.
Latest Holdings of Tsveta Milanova
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2024-01-24 | 13,234 | 58.97 | 780,409 |
Holding Weightings of Tsveta Milanova
Tsveta Milanova Form 4 Trading Tracker
According to the SEC Form 4 filings, Tsveta Milanova has made a total of 3 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 1,618 shares on January 24, 2024, which brought Tsveta Milanova around $35,014.
Insider Trading History of Tsveta Milanova
- 1
Tsveta Milanova Trading Performance
Tsveta Milanova Ownership Network
Ownership Network List of Tsveta Milanova
Ownership Network Relation of Tsveta Milanova
Tsveta Milanova Owned Company Details
What does Agios Pharmaceuticals Inc do?
Who are the key executives at Agios Pharmaceuticals Inc?
Tsveta Milanova is the Chief Commercial Officer of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include Chief Legal Officer James William Burns , Chief Financial Officer Cecilia Jones , and director & Chief Executive Officer Brian Goff .
Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary
Over the past 18 months, Tsveta Milanova made 3 insider transaction in Agios Pharmaceuticals Inc (AGIO) with a net sale of 6,138. Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 35,912 shares made by James William Burns , a net sale of 9,416 shares made by Washburn Theodore James Jr. , and a net sale of 64,534 shares made by Brian Goff .
In summary, during the past 3 months, insiders sold 44,294 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 44,294 shares. During the past 18 months, 294,348 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 294,348 shares.
Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agios Pharmaceuticals Inc Insider Transactions
Tsveta Milanova Mailing Address
Above is the net worth, insider trading, and ownership report for Tsveta Milanova. You might contact Tsveta Milanova via mailing address: C/o Agios Pharmaceuticals, Inc., 88 Sidney Sreet, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
